D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
INBX holding history
Inhibrx Biosciences, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
INBX overviewAll 13F holders of INBXFull Q2 2026 holdings
- Shares (Q2 2026)
- 22,322
- Value
- $2.12M
- % of portfolio
- <0.1%
- Quarters held
- 11
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 22,322 | $2.12M | <0.1% | −55,115−71.2% | Reduced | Holders |
| Q1 2026 | 77,437 | $5.21M | <0.1% | −44,664−36.6% | Reduced | Holders |
| Q4 2025 | 122,101 | $9.65M | <0.1% | +110,548+956.9% | Added | Holders |
| Q3 2025 | 11,553 | $389.1K | <0.1% | +11,553 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −35,497−100.0% | Sold out | Holders |
| Q2 2023 | 35,497 | $921.5K | <0.1% | −55,353−60.9% | Reduced | Holders |
| Q1 2023 | 90,850 | $1.71M | <0.1% | −10,390−10.3% | Reduced | Holders |
| Q4 2022 | 101,240 | $2.49M | <0.1% | +31,521+45.2% | Added | Holders |
| Q3 2022 | 69,719 | $1.25M | <0.1% | −51,293−42.4% | Reduced | Holders |
| Q2 2022 | 121,012 | $1.37M | <0.1% | +85,016+236.2% | Added | Holders |
| Q1 2022 | 35,996 | $802.0K | <0.1% | +22,187+160.7% | Added | Holders |
| Q4 2021 | 13,809 | $603.0K | <0.1% | +13,809 | New | Holders |